INMD
InMode LtdNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$906.66M
P/E Ratio
10.08
EPS
$1.42
Beta
1.98
52W High
$16.74
52W Low
$12.72
50-Day MA
$13.84
200-Day MA
$14.47
Dividend Yield
—
Profit Margin
25.30%
Forward P/E
9.94
PEG Ratio
0.83
About InMode Ltd
InMode Ltd. designs, develops, manufactures and markets minimally invasive aesthetic medical products based on its proprietary RF-assisted lipolysis and deep subdermal fractional RF technologies. The company is headquartered in Yokneam, Israel.
Fundamentals
| Revenue (TTM) | $370.50M |
| Gross Profit (TTM) | $290.97M |
| EBITDA | $86.08M |
| Operating Margin | 25.00% |
| Return on Equity | 13.50% |
| Return on Assets | 6.88% |
| Revenue/Share (TTM) | $5.73 |
| Book Value | $10.78 |
| Price-to-Book | 1.34 |
| Price-to-Sales (TTM) | 2.45 |
| EV/Revenue | 0.988 |
| EV/EBITDA | 4.25 |
| Quarterly Earnings Growth (YoY) | -63.50% |
| Quarterly Revenue Growth (YoY) | 6.10% |
| Shares Outstanding | $63.36M |
| Float | $54.93M |
| % Insiders | 11.91% |
| % Institutions | 54.47% |
Historical Volatility
HV 10-Day
22.51%
HV 20-Day
22.69%
HV 30-Day
21.34%
HV 60-Day
30.35%
HV Rank
9.1%
Volatility is currently expanding
Analyst Ratings
Consensus ($17.00 target)
1
Strong Buy5
HoldMore HEALTHCARE Stocks
Data last updated: 5/5/2026